RAY DEBANJAN

CIK 00017068631 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001706863

Recent Transactions

50 trades

Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (right to buy)
2019-01-25+90,000→ 90,000 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-12-12$1.45/sh+3,000→ 8,928 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-12-12−3,000→ 7,220 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-12-12$15.00/sh−3,000→ 5,928 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-11-01−3,000→ 10,220 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-11-01$1.45/sh+3,000→ 8,928 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-11-01$15.00/sh−3,000→ 5,928 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-10-01−3,000→ 13,220 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-10-01$18.46/sh−3,000→ 5,928 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-10-01$1.45/sh+3,000→ 8,928 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-09-04+3,000→ 16,220 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-09-04$22.39/sh−3,000→ 5,928 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-09-04$1.45/sh+3,000→ 8,928 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-08-01+290→ 19,220 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-08-01+2,710→ 0 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-08-01$1.45/sh+290→ 8,928 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-08-01$1.26/sh+2,710→ 8,638 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-08-01$26.05/sh−3,000→ 5,928 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-07-02$1.26/sh+3,000→ 8,928 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-07-02$22.56/sh−3,000→ 5,928 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-07-02−3,000→ 2,710 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-06-01−3,000→ 5,710 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-06-01$25.93/sh−3,000→ 5,928 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-06-01$1.26/sh+3,000→ 8,928 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-05-31$17.90/sh+1,187→ 5,928 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-05-01−3,000→ 8,710 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-05-01$1.26/sh+3,000→ 7,741 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-05-01$26.52/sh−3,000→ 4,741 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-04-02−3,000→ 11,710 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-04-02$1.26/sh+3,000→ 7,741 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-04-02$28.12/sh−3,000→ 4,741 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-03-02−14,485→ 20,000 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-03-02−5,515→ 14,710 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-03-02$1.26/sh+5,515→ 10,256 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-03-02$30.06/sh−5,515→ 4,741 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-03-02$1.13/sh+14,485→ 19,226 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-03-02$30.41/sh−12,541→ 6,685 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-03-02$31.02/sh−1,944→ 4,741 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-03-01$29.40/sh−13,000→ 4,741 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-03-01$1.26/sh+13,000→ 17,741 total
Exercise/Conversion
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2018-03-01−13,000→ 20,225 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-02-01$26.69/sh−2,548→ 4,741 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (right to buy)
2018-01-24+100,000→ 100,000 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2018-01-02$21.11/sh−2,500→ 7,289 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2017-12-01$20.58/sh−2,500→ 9,789 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2017-11-30$12.15/sh+163→ 12,289 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2017-11-01$20.00/sh−2,500→ 12,126 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2017-10-02$18.10/sh−2,500→ 14,626 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2017-09-01$17.17/sh−2,500→ 17,126 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2017-08-09$15.00/sh−2,500→ 19,626 total

Companies

CytomX Therapeutics, Inc.
Chief Financial Officer
$CTMX

Recent Filings

Address

C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., SUITE 400

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov